FI102613B1 - Menetelmä NMDA-antagonistien valmistamiseksi - Google Patents

Menetelmä NMDA-antagonistien valmistamiseksi

Info

Publication number
FI102613B1
FI102613B1 FI904588A FI904588A FI102613B1 FI 102613 B1 FI102613 B1 FI 102613B1 FI 904588 A FI904588 A FI 904588A FI 904588 A FI904588 A FI 904588A FI 102613 B1 FI102613 B1 FI 102613B1
Authority
FI
Finland
Prior art keywords
preparation
nmda antagonists
nmda
antagonists
Prior art date
Application number
FI904588A
Other languages
English (en)
Swedish (sv)
Other versions
FI102613B (fi
FI904588A0 (fi
Inventor
Jeffrey Paul Whitten
Bruce Michael Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/553,431 external-priority patent/US5095009A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI904588A0 publication Critical patent/FI904588A0/fi
Application granted granted Critical
Publication of FI102613B publication Critical patent/FI102613B/fi
Publication of FI102613B1 publication Critical patent/FI102613B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI904588A 1989-09-19 1990-09-18 Menetelmä NMDA-antagonistien valmistamiseksi FI102613B1 (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US40947889A 1989-09-19 1989-09-19
US40947889 1989-09-19
US50833390A 1990-04-11 1990-04-11
US50833390 1990-04-11
US55343190 1990-07-20
US07/553,431 US5095009A (en) 1990-04-11 1990-07-20 NMDA antagonists

Publications (3)

Publication Number Publication Date
FI904588A0 FI904588A0 (fi) 1990-09-18
FI102613B FI102613B (fi) 1999-01-15
FI102613B1 true FI102613B1 (fi) 1999-01-15

Family

ID=27410806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904588A FI102613B1 (fi) 1989-09-19 1990-09-18 Menetelmä NMDA-antagonistien valmistamiseksi

Country Status (20)

Country Link
EP (1) EP0418863B1 (fi)
JP (1) JP2934295B2 (fi)
KR (2) KR100191116B1 (fi)
CN (1) CN1027694C (fi)
AR (2) AR247889A1 (fi)
AT (1) ATE116653T1 (fi)
AU (1) AU632362B2 (fi)
CA (1) CA2025326C (fi)
DE (1) DE69015745T2 (fi)
DK (1) DK0418863T3 (fi)
ES (1) ES2069644T3 (fi)
FI (1) FI102613B1 (fi)
GR (1) GR3015656T3 (fi)
HU (1) HU207523B (fi)
IE (1) IE65118B1 (fi)
IL (1) IL95718A (fi)
MX (1) MX9203696A (fi)
NO (1) NO178375C (fi)
NZ (1) NZ235322A (fi)
PT (1) PT95344B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554773A (en) * 1991-11-15 1996-09-10 Merrell Pharmaceuticals Inc. N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists
ES2087555T3 (es) * 1991-11-15 1996-07-16 Merrell Pharma Inc Derivados de acido n-tritilo aspartico utilizados para la preparacion de antagonistas de fosfonato nmda.
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
EP0684238A3 (en) * 1994-04-27 1997-01-15 Hoffmann La Roche Process for the preparation of dicarboxamides.
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970684A (en) * 1973-07-06 1976-07-20 Syntex (U.S.A.) Inc. Polyunsaturated prostaglandin derivatives
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
PT95344A (pt) 1991-06-25
FI102613B (fi) 1999-01-15
DK0418863T3 (da) 1995-03-20
DE69015745D1 (de) 1995-02-16
IE65118B1 (en) 1995-10-04
DE69015745T2 (de) 1995-05-11
EP0418863A2 (en) 1991-03-27
PT95344B (pt) 1998-02-27
MX9203696A (es) 1992-09-01
EP0418863B1 (en) 1995-01-04
NO904061D0 (no) 1990-09-18
CN1027694C (zh) 1995-02-22
KR100191116B1 (ko) 1999-06-15
NO178375B (no) 1995-12-04
KR100196265B1 (ko) 1999-06-15
AU6247490A (en) 1991-03-28
GR3015656T3 (en) 1995-07-31
CA2025326A1 (en) 1991-03-20
CN1050387A (zh) 1991-04-03
IE903380A1 (en) 1991-04-10
ES2069644T3 (es) 1995-05-16
HU207523B (en) 1993-04-28
NZ235322A (en) 1993-02-25
HUT54699A (en) 1991-03-28
KR910006311A (ko) 1991-04-29
FI904588A0 (fi) 1990-09-18
ATE116653T1 (de) 1995-01-15
EP0418863A3 (en) 1991-06-12
AR248028A1 (es) 1995-05-31
AR247889A1 (es) 1995-04-28
NO904061L (no) 1991-03-20
CA2025326C (en) 2001-04-24
JPH03130295A (ja) 1991-06-04
AU632362B2 (en) 1992-12-24
NO178375C (no) 1996-03-13
IL95718A (en) 1998-03-10
JP2934295B2 (ja) 1999-08-16

Similar Documents

Publication Publication Date Title
PT87508A (pt) A process for the preparation of highly soluble clear polyimides
PT93785A (pt) Processo para a preparacao de derivados de 3-substituido-2-oxindole
DK0429760T3 (da) Fremgangsmåde til fremstilling af et aromatiseringsmiddel
ZA906536B (en) Process for the preparation of a polyefin
FI92403C (fi) Menetelmä Cefodizim-dinatriumin valmistamiseksi
NO901232D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
PT93629A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina
BR9001503A (pt) Processo para a preparacao de alquil-halogenossilanos
IS3589A7 (is) Aðferð við framleiðslu á efnasambandinu Indenoindoles I
NO903513D0 (no) Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister.
FI102613B1 (fi) Menetelmä NMDA-antagonistien valmistamiseksi
PT93631A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina
FI97542B (fi) Uusi menetelmä 9-amino-1,2,3,4-tetrahydroakridiinien valmistamiseksi
NO902460D0 (no) Fremgangsmaate for fremstilling av en natriumpolyacrylatgel
FI901358A0 (fi) Menetelmä fluorifenolien valmistamiseksi
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
FI93363C (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
GB9027816D0 (en) Process for the preparation of a novel intermediate
PT87528A (pt) Process for the preparation of vasopressin antagonists
ZA907310B (en) Nmda antagonists
PH25815A (en) A process for the preparation of aluminoxanes
EE03762B1 (et) Protsess NMDA antagonistide valmistamiseks
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi
TH7144EX (th) กรรมวิธีสำหรับเตรียม n-ซัลโฟนิล ยูเรีย

Legal Events

Date Code Title Description
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.